Newborn Screening Market Is Poised To Flourish At A CAGR Of 7.8% to Reach a Value of US$ 1.1 Billion by the End Of 2032

Award-winning consulting firm Fact.MR’s recent report on the newborn screening market forecasts an optimistic outlook, predicting a CAGR surpassing 8% to reach a valuation of over US$ 1 billion by 2031. Increased spending on infant care in the wake of accelerating birth rates is principally driving demand for newborn screening solutions.

The market posted impressive gains in the past, expanding at under 8% CAGR from 2016 to 2020. Stakeholders have been inclining specifically towards the use of newborn screening consumables to predict highly accurate outcomes and growing hygiene concerns associated with reusable screening products.

According to the World Health Organization, the world has seen a dramatic reduction to the tune of 60% in the under-five category, from 93 deaths per 1,000 live births in 1990 to 38 in 2019. However, global burden of child and youth death remains high, with over 7 million children, adolescents, and youth aged 0-14 years succumbing to preventable diseases. Consequently, governments across key regions are spending on improving existing infant care infrastructure, prompting the entry of key newborn screening solutions providers.

Download Free Sample Copy of This Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6323

Newborn Screening Market (2031)	US$ 1 billion
Global Market Growth Rate – 2031	8% CAGR
Segments	End-use industry, Type, and Region
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

How are Surging Cases of Infant Disorders Stimulating Newborn Screening Demand?

Prevalence of infant diseases has multiplied in recent years, causing a sharp incline in mortality rates. Hearing impairment, metabolic and hormonal disorders are some most common conditions affecting newborns across prominent regions, which are mostly treatable.

According to the Centers for Disease Control & Prevention (CDC), birth defects affect one in every 33 babies, or 3% of all infants, across the United States. Furthermore, the Indian Academy of Pediatrics (IAP) estimates that congenital hearing loss impacts 30 per 100,000 children.

Consequently, demand for effective diagnostic solutions has compounded, prompting key healthcare providers to invest in advanced newborn screening approaches, generating increased demand.

Key Market Segments Covered
Product

• Newborn Screening Instruments
  • Disorder Screening Instruments
    • Fully Automated Newborn Screening Instruments
    • Other Newborn Screening Instruments (Semi-automated Instruments, Shakers, Incubators, etc.)
  • Hearing Screening Instruments
    • Newborn Screening Accessories
    • Newborn Screening Devices
  • Pulse Oximeters
• Consumables
  • Newborn Screening Assay Kits & Reagents
  • Other Newborn Screening Consumables (Columns and Screening Cards)

Test Type

• Dry Blood Spot Newborn Screening Tests
• Newborn Hearing Screening Tests
• Critical Congenital Heart Disease (CCHD) Screening Tests

Technology

• Newborn Immunoassays & Enzymatic Screening Tests
• Tandem Mass Spectrometry
• Molecular Assays
• Newborn Hearing Screening Technologies
• Pulse Oximetry
• Other Newborn Screening Technologies (Fluorescence, Gel Electrophoresis, etc.)

End User

• Newborn Screening at Clinical Laboratories
• Newborn Screening at Hospitals

Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=6323

Competitive Landscape

Prominent newborn screening providers are reliant on such key expansion strategies as product portfolio expansion by virtue of new releases, acquisition of existing manufacturers and entering into strategic agreements and collaborations. These measures help existing providers secure a firm footing in the market.

• For instance, Bio-Rad Laboratories offers the VARIANTnbs automated newborn screening for sickle cell disease and other hemoglobin disorders, featuring fully automated analysis and advanced result reporting for maximum efficiency. It uses dried blood spot specimens to provide results.
• Recently, in May 2021, Baebies was awarded US$ 2.7 million in a Phase-II B SBIR grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) which supports validation, clinical evaluation and FDA submission of a rapid test panel for near-patient heparin monitoring.

Key Companies Profiled

• PerkinElmer
• Demant A/S
• Natus Medical Inc.
• Bio-Rad Laboratories
• Danaher Corporation
• Medtronic Plc.
• Chromsystems Instruments & Chemicals GmbH
• Trivitron Healthcare
• Baebies
• RECIPE Chemicals + Instruments GmbH

Why is the U.S. Likely to Generate Significant Opportunities for Newborn Screening Product Manufacturers?

Prospects for newborn screening across the U.S. are expected to take a turn for the better, with an anticipated CAGR of around 5% throughout the forecast period. The Center for Disease Control and Prevention (CDC) estimates that millions of babies are routinely screened every year.

Testing for possible diseases or conditions is largely administered via blood samples drawn from a newborn’s heel for genetic, endocrine or metabolic disorders, as well as for congenital heart defects. Players such as PerkinElmer and Danaher Corporation actively provide various newborn screening solutions.

For In-Depth Competitive Analysis, Buy now – https://www.factmr.com/checkout/6323

Why are Newborn Screening Consumables Gaining Traction?

Based on product, demand for newborn screening consumables is poised to witness impressive growth, expanding at a CAGR of nearly 8% until 2031. This elevated share is an outcome of growing hygiene concerns, especially in the wake of the recent pandemic crisis.

Amongst all consumables, demand for assay kits & reagents shall remain elevated, attributed to their ability to produce faster output times which helps in timely detection and diagnosis or prevention of any serious pediatric conditions.

Check Out More Related Studies Published By Fact.MR Research:

Medical Case Management Service Market – Demand for healthcare medical case management services is expected to be prominent across the globe by the end of this decade. However, currently the demand is only expected to be observed in the developed regions. The lack of awareness in the under developed regions is majorly hindering the growth of medical case management services industry in these regions.

Medical Flexible Packaging Market – The extensive use of flexible packaging solutions in the pharmaceutical and medical sectors is driving the market growth. Owing to the low weight, product variety, less requirement of the raw material coupled with easy disposal is expected to support market demand by 1.4X in forecast years of 2022-2032.

Medical Beds Market – The global medical beds market amassed revenue worth US$ 3.8 Bn in 2020. Fact.MR, a market research and competitive intelligence provider, has recently published a revised analysis, which estimates the market to rise at a CAGR of 3.7% and be valued at around US$ 5.5 Bn by 2031.

Medical Superabsorbent Polymers Market – Fact.MR estimates medical superabsorbent polymers market value to reach USD 5,663 Million valuation by 2032 end, and shall account for nearly 30% of the overall superabsorbent polymer sales value during the same period.

Medical Polymers Market – The medical polymers market is projected to surge at a CAGR of 8.2% over the period of 2021 to 2031. Higher anticipated surge in demand is primarily due to rise in spending of regional governments to strengthen their healthcare infrastructure, post COVID-era.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.